⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23442 | 0.67 | — | — | |
| SCHEMBL9818338 | 0.61 | — | — | |
| SCHEMBL156284 | 0.60 | — | — | |
| SCHEMBL29366220 | 0.60 | — | — | |
| SCHEMBL4427633 | 0.60 | CHEK1 (0.44) | — | |
| SCHEMBL7743692 | 0.60 | CHEK1 (0.44) | — | |
| SCHEMBL2772908 | 0.60 | CHEK1 (0.44) | — | |
| Hydrochloric Acid SCHEMBL30144023 | 0.59 | CLK1 (0.53) | — | |
| Hydrochloric Acid SCHEMBL15543266 | 0.59 | CLK1 (0.53) | — | |
| Indazole SCHEMBL29355507 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 228 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357268-A1 | PREPARATION AND APPLICATION OF TRICYCLIC PYRIMIDINONE COMPOUND AND ITS COMPOSITION | NEUSCO BIOTECH LIMITED (CN) | 2023-11-09 | — | — | US | claimed |
| US-20230271980-A1 | PREPARATION AND APPLICATION OF TRICYCLIC PYRIMIDINONE COMPOUND AND ITS COMPOSITION | NEUSCO BIOTECH LIMITED (CN) | 2023-08-31 | — | — | US | claimed |
| US-20230242532-A1 | TETRACYCLIC PYRIMIDINONE COMPOUND, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF | NEUSCO BIOTECH LIMITED (CN) | 2023-08-03 | — | — | US | claimed |
| US-20230212168-A1 | ENDOCYCLIC PYRIMIDINONE COMPOUNDS, AND PREPARATION METHODS, COMPOSITIONS AND USE THEREOF | NEUSCO BIOTECH LIMITED (CN) | 2023-07-06 | — | — | US | claimed |
| EP-4180436-A1 | TRICYCLIC PYRIMIDINONE COMPOUND, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF | Neusco Biotech Limited (CN) | 2023-05-17 | — | — | EP | claimed |
| EP-4174070-A1 | TRICYCLIC PYRIMIDINONE COMPOUND, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF | Neusco Biotech Limited (CN) | 2023-05-03 | — | — | EP | claimed |
| EP-4151638-A1 | BRIDGED CYCLIC PYRIMIDINONE COMPOUND, PREPARATION METHOD THEREFOR, COMPOSITION CONTAINING SAME AND USE THEREOF | Neusco Biotech Limited (CN) | 2023-03-22 | — | — | EP | claimed |
| EP-2744812-B1 | THERAPEUTICALLY ACTIVE FUSED PYRIMIDINE DERIVATIVES | UCB BIOPHARMA SPRL (BE) | 2016-07-20 | — | — | EP | claimed |
| EP-2236135-A1 | STABLE PHARMACEUTICAL COMPOSITION | Asahi Kasei Pharma Corporation (JP) | 2010-10-06 | — | — | EP | claimed |
| US-20100048893-A1 | Substituted arylalkanoic acid derivatives and use thereof | ASAHI KASEI PHARMA CORPORATION (JP) | 2010-02-25 | — | — | US | claimed |
| US-20100041725-A1 | STABLE PHARMACEUTICAL COMPOSITION | ASAHI KASEI PHARMA CORPORATION (JP) | 2010-02-18 | — | — | US | claimed |
| EP-2006271-A9 | SUBSTITUTED BICYCLIC CYCLIC DERIVATIVE AND USE THEREOF | Asahi Kasei Pharma Corporation (JP) | 2009-07-29 | — | — | EP | claimed |
| US-20090054401-A1 | Substituted bicyclic derivatives and use thereof | ASAHI KASEI PHARMA CORPORATION (JP) | 2009-02-26 | — | — | US | claimed |
| US-7470807-B2 | Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate | ASAHI KASEI PHARMA CORPORATION (JP) | 2008-12-30 | — | — | US | claimed |
| EP-2006271-A2 | SUBSTITUTED BICYCLIC CYCLIC DERIVATIVE AND USE THEREOF | Asahi Kasei Pharma Corporation (JP) | 2008-12-24 | — | — | EP | claimed |
| US-20070213333-A1 | Substituted arylalkanoic acid derivatives and use thereof | ASAHI KASEI PHAMA CORPORATION (JP) | 2007-09-13 | — | — | US | claimed |
| EP-1660427-A4 | SUBSTITUTED ARYLALKANOIC ACID DERIVATIVE AND USE THEREOF | ASAHI KASEI PHARMA CORP (JP) | 2006-12-20 | — | — | EP | claimed |
| EP-1660427-A1 | SUBSTITUTED ARYLALKANOIC ACID DERIVATIVE AND USE THEREOF | Asahi Kasei Pharma Corporation (JP) | 2006-05-31 | — | — | EP | claimed |
| WO-2005016862-A1 | SUBSTITUTED ARYLALKANOIC ACID DERIVATIVE AND USE THEREOF | ASAHI KASEI PHARMA CORPORATION (JP) | 2005-02-24 | — | — | WO | claimed |
| US-20240230711-A1 | GAS SENSOR, SCANNING ELECTROCHEMICAL GAS MICROSCOPE, AND METHOD OF PREPARING GAS SENSOR | UIF (UNIVERSITY INDUSTRY FOUNDATION), YONSEI UNIVERSITY (KR) | 2024-07-11 | — | — | US | disclosed |
| US-20240234813-A1 | POSITIVE ELECTRODE FOR SOLID LITHIUM BATTERY, SOLID LITHIUM BATTERY INCLUDING THE SAME, AND METHOD OF PREPARING POSITIVE ELECTRODE FOR SOLID BATTERY | SAMSUNG ELECTRONICS CO LTD (KR) | 2024-07-11 | — | — | US | disclosed |
| EP-3603646-B1 | VITAMIN D3 AND ANALOGS THEREOF FOR TREATING ALOPECIA | BPGBIO INC (US) | 2024-04-03 | — | — | EP | disclosed |
| US-11926695-B2 | High-thermal conductive epoxy compound and composition, material for semiconductor package, molded product, electric and electronic device, and semiconductor package including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-03-12 | — | — | US | disclosed |
| EP-3003497-B1 | PREVENTING OR MITIGATING CHEMOTHERAPY INDUCED ALOPECIA USING VITAMIN D | BPGBIO INC (US) | 2024-02-14 | — | — | EP | disclosed |
| US-20230357268-A1 | PREPARATION AND APPLICATION OF TRICYCLIC PYRIMIDINONE COMPOUND AND ITS COMPOSITION | NEUSCO BIOTECH LIMITED (CN) | 2023-11-09 | — | — | US | disclosed |
| US-20230302022-A1 | PREVENTING OR MITIGATING CHEMOTHERAPY INDUCED ALOPECIA USING VITAMIN D | BERG SURVIVOR’S TRUST | 2023-09-28 | — | — | US | disclosed |
| US-20230271980-A1 | PREPARATION AND APPLICATION OF TRICYCLIC PYRIMIDINONE COMPOUND AND ITS COMPOSITION | NEUSCO BIOTECH LIMITED (CN) | 2023-08-31 | — | — | US | disclosed |
| US-20230242532-A1 | TETRACYCLIC PYRIMIDINONE COMPOUND, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF | NEUSCO BIOTECH LIMITED (CN) | 2023-08-03 | — | — | US | disclosed |
| US-20230212168-A1 | ENDOCYCLIC PYRIMIDINONE COMPOUNDS, AND PREPARATION METHODS, COMPOSITIONS AND USE THEREOF | NEUSCO BIOTECH LIMITED (CN) | 2023-07-06 | — | — | US | disclosed |
| US-20230194460-A1 | GAS SENSOR, SCANNING ELECTROCHEMICAL GAS MICROSCOPE, AND METHOD OF PREPARING GAS SENSOR | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2023-06-22 | — | — | US | disclosed |
| US-20230183237-A1 | COMPETITIVE AND NONCOMPETITIVE INHIBITORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M5 | VANDERBILT UNIVERSITY | 2023-06-15 | — | — | US | disclosed |
| US-20230163272-A1 | ANODE INTERLAYER FOR ALL- SOLID SECONDARY BATTERY, ALL-SOLID SECONDARY BATTERY COMPRISING ANODE INTERLAYER, AND METHOD OF CHARGING ALL-SOLID SECONDARY BATTERY | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-05-25 | — | — | US | disclosed |
| EP-4180436-A1 | TRICYCLIC PYRIMIDINONE COMPOUND, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF | Neusco Biotech Limited (CN) | 2023-05-17 | — | — | EP | disclosed |
| US-11643398-B2 | Metallic salt containing anion having heterocyclic aromatic structure, method of preparing the metallic salt, and electrolyte and electrochemical device each including the metallic salt | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-05-09 | — | — | US | disclosed |
| EP-4174070-A1 | TRICYCLIC PYRIMIDINONE COMPOUND, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF | Neusco Biotech Limited (CN) | 2023-05-03 | — | — | EP | disclosed |
| EP-3657590-B1 | METALLIC SALT CONTAINING ANION HAVING HETEROCYCLIC AROMATIC STRUCTURE, METHOD OF PREPARING THE SAME, AS WELL AS ELECTROLYTE AND ELECTROCHEMICAL DEVICE EACH INCLUDING THE METALLIC SALT | SAMSUNG ELECTRONICS CO LTD (KR) | 2023-04-26 | — | — | EP | disclosed |
| EP-4153601-A1 | COMPETITIVE AND NONCOMPETITIVE INHIBITORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M5 | Vanderbilt University (US) | 2023-03-29 | — | — | EP | disclosed |
| EP-4151638-A1 | BRIDGED CYCLIC PYRIMIDINONE COMPOUND, PREPARATION METHOD THEREFOR, COMPOSITION CONTAINING SAME AND USE THEREOF | Neusco Biotech Limited (CN) | 2023-03-22 | — | — | EP | disclosed |
| CN-115667273-A | Competitive and non-competitive inhibitors of muscarinic acetylcholine receptor M5 | 范德堡大学 | 2023-01-31 | — | — | CN | disclosed |
| US-20220023317-A1 | PREVENTING OR MITIGATING CHEMOTHERAPY INDUCED ALOPECIA USING VITAMIN D | BERG SURVIVOR’S TRUST | 2022-01-27 | — | — | US | disclosed |
| WO-2022001881-A1 | TRICYCLIC PYRIMIDINONE COMPOUND, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF | 上海纽思克生物科技有限公司 | 2022-01-06 | — | — | WO | disclosed |
| WO-2021237038-A1 | COMPETITIVE AND NONCOMPETITIVE INHIBITORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M5 | VANDERBILT UNIVERSITY (US) | 2021-11-25 | — | — | WO | disclosed |
| US-20210170043-A1 | DC-SIGN ANTIBODY CONJUGATES COMPRISING STING AGONISTS | CHINOOK THERAPEUTICS, INC. | 2021-06-10 | — | — | US | disclosed |
| US-20210147612-A1 | HIGH-THERMAL CONDUCTIVE EPOXY COMPOUND AND COMPOSITION, MATERIAL FOR SEMICONDUCTOR PACKAGE, MOLDED PRODUCT, ELECTRIC AND ELECTRONIC DEVICE, AND SEMICONDUCTOR PACKAGE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-05-20 | — | — | US | disclosed |
| US-20210147613-A1 | HIGHLY THERMALLY CONDUCTIVE EPOXY COMPOUND, AND COMPOSITION, MATERIAL FOR SEMICONDUCTOR PACKAGE, MOLDED PRODUCT, ELECTRIC AND ELECTRONIC DEVICE AND SEMICONDUCTOR PACKAGE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-05-20 | — | — | US | disclosed |
| US-10944120-B2 | Polymer electrolyte, method of preparing the polymer electrolyte, and lithium metal battery including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-03-09 | — | — | US | disclosed |
| US-10892422-B2 | Compound for organic optoelectronic device, organic light emitting diode including the same, and display including the organic light emitting diode | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-01-12 | — | — | US | disclosed |
| EP-3657590-A1 | METALLIC SALT CONTAINING ANION HAVING HETEROCYCLIC AROMATIC STRUCTURE, METHOD OF PREPARING THE SAME, AS WELL AS ELECTROLYTE AND ELECTROCHEMICAL DEVICE EACH INCLUDING THE METALLIC SALT | Samsung Electronics Co., Ltd. (KR) | 2020-05-27 | — | — | EP | disclosed |
| US-20200157058-A1 | METALLIC SALT CONTAINING ANION HAVING HETEROCYCLIC AROMATIC STRUCTURE, METHOD OF PREPARING THE METALLIC SALT, AND ELECTROLYTE AND ELECTROCHEMICAL DEVICE EACH INCLUDING THE METALLIC SALT | SAMSUNG SDI CO., LTD. (KR) | 2020-05-21 | — | — | US | disclosed |
| EP-3316361-B1 | POLYMER ELECTROLYTE, METHOD OF PREPARING THE POLYMER ELECTROLYTE, AND LITHIUM METAL BATTERY INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD (KR) | 2020-04-29 | — | — | EP | disclosed |
| US-20200113918-A1 | PREVENTING OR MITIGATING CHEMOTHERAPY INDUCED ALOPECIA USING VITAMIN D | BERG LLC | 2020-04-16 | — | — | US | disclosed |
| EP-3615080-A1 | ANTIBODY CONJUGATES COMPRISING STING AGONIST | Novartis AG (CH) | 2020-03-04 | — | — | EP | disclosed |
| EP-3603646-A1 | VITAMIN D3 AND ANALOGS THEREOF FOR TREATING ALOPECIA | Berg LLC (US) | 2020-02-05 | — | — | EP | disclosed |
| US-20190343847-A1 | PREVENTING OR MITIGATING CHEMOTHERAPY INDUCED ALOPECIA USING VITAMIN D | BERG LLC (US) | 2019-11-14 | — | — | US | disclosed |
| US-10388990-B2 | Electrolyte for lithium secondary battery and lithium secondary battery using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-08-20 | — | — | US | disclosed |
| US-10355284-B2 | Composition, method of preparing the composition, electrode including the composition, and fuel cell including the electrode | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-07-16 | — | — | US | disclosed |
| US-20190151312-A1 | HEPARAN SULFATE BIOSYNTHESIS INHIBITORS FOR THE TREATMENT OF DISEASES | BIOMARIN PHARMACEUTICAL INC. | 2019-05-23 | — | — | US | disclosed |
| EP-2464357-B1 | VITAMIN D3 AND ANALOGS THEREOF FOR TREATING ALOPECIA | BERG LLC (US) | 2019-05-22 | — | — | EP | disclosed |
| EP-3463283-A1 | PREVENTING OR MITIGATING CHEMOTHERAPY INDUCED ALOPECIA USING VITAMIN D | Berg LLC (US) | 2019-04-10 | — | — | EP | disclosed |
| US-20180369381-A1 | VITAMIN D3 AND ANALOGS THEREOF FOR TREATING ALOPECIA | THLIVERIS, ANDREW T. | 2018-12-27 | — | — | US | disclosed |
| WO-2018200812-A1 | ANTIBODY CONJUGATES COMPRISING STING AGONIST | NOVARTIS AG (CH) | 2018-11-01 | — | — | WO | disclosed |
| US-20180153861-A1 | METHOD OF TREATING ATHEROSCLEROSIS IN HIGH TRIGLYCERIDE SUBJECTS | NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC. | 2018-06-07 | — | — | US | disclosed |
| EP-2729142-B1 | METHOD OF TREATING ATHEROSCLEROSIS IN HIGH TRIGLYCERIDE SUBJECTS | NOVARTIS AG (CH) | 2018-05-09 | — | — | EP | disclosed |
| EP-3316361-A1 | POLYMER ELECTROLYTE, METHOD OF PREPARING THE POLYMER ELECTROLYTE, AND LITHIUM METAL BATTERY INCLUDING THE SAME | Samsung Electronics Co., Ltd. (KR) | 2018-05-02 | — | — | EP | disclosed |
| US-20180115006-A1 | POLYMER ELECTROLYTE, METHOD OF PREPARING THE POLYMER ELECTROLYTE, AND LITHIUM METAL BATTERY INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-04-26 | — | — | US | disclosed |
| US-9911924-B2 | Material for organic optoelectronic device, organic light emitting diode including the same, and display including the organic light emitting diode | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-03-06 | — | — | US | disclosed |
| US-9901637-B2 | Vitamin D3 and analogs thereof for treating alopecia | BERG LLC (US) | 2018-02-27 | — | — | US | disclosed |
| US-9899604-B2 | Compound for organic optoelectronic device, organic light emitting diode including the same, and display including the organic light emitting diode | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-02-20 | — | — | US | disclosed |
| US-20180026306-A1 | ELECTROLYTE FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY USING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-01-25 | — | — | US | disclosed |
| US-9867811-B2 | Method of treating atherosclerosis in high triglyceride subjects | NOVARTIS AG (CH) | 2018-01-16 | — | — | US | disclosed |
| EP-2993169-B1 | ARYL-PYRIDINE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS | NOVARTIS AG (CH) | 2017-12-20 | — | — | EP | disclosed |
| WO-2017214064-A1 | PREVENTING OR MITIGATING CHEMOTHERAPY INDUCED ALOPECIA USING VITAMIN D | BERG LLC (US) | 2017-12-14 | — | — | WO | disclosed |
| US-9819054-B2 | Electrolyte for lithium secondary battery and lithium secondary battery using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-11-14 | — | — | US | disclosed |
| US-9798057-B2 | Composition for polarization film, polarization film, and display device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-10-24 | — | — | US | disclosed |
| US-9722270-B2 | Polymer, electrolyte membrane and electrode for a fuel cell, each including the polymer, fuel cell including at least one of the electrolyte membrane, and the electrode | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-08-01 | — | — | US | disclosed |
| US-9680156-B2 | Composition, polymer thereof, electrode and electrolyte membrane for fuel cell, and fuel cell including the same | SAMSUNG ELECTRONICS CO., LTD (KR) | 2017-06-13 | — | — | US | disclosed |
| US-9627629-B2 | Compound for organic optoelectronic device, organic light emitting diode including the same, and display including the organic light emitting diode | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-04-18 | — | — | US | disclosed |
| US-9603819-B2 | Substituted aminobutyric derivatives as neprilysin inhibitors | NOVARTIS AG (CH) | 2017-03-28 | — | — | US | disclosed |
| US-9597344-B2 | Sonosensitive liposome, pharmaceutical composition including the same, and method of delivering active agent to subject using the sonosensitive liposome | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-03-21 | — | — | US | disclosed |
| US-9515341-B2 | Porous membrane, electrolyte membrane including same, methods of manufacturing both, and fuel cell including at least one of the membranes | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-12-06 | — | — | US | disclosed |
| US-9484588-B2 | Compound, composition including compound, composite formed therefrom, electrode using composition or composite, composite membrane using composite, and fuel cell including at least one selected from electrode and composite membrane | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-11-01 | — | — | US | disclosed |
| US-9472806-B2 | Polymer, electrode for lithium batteries including the polymer, and lithium battery including the electrode | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-10-18 | — | — | US | disclosed |
| EP-2560227-B1 | Porous membrane, electrolyte membrane including same, methods of manufacturing both, and fuel cell including at least one of the membranes | SAMSUNG ELECTRONICS CO LTD (KR) | 2016-10-12 | — | — | EP | disclosed |
| US-20160268609-A1 | COMPOSITION, METHOD OF PREPARING THE COMPOSITION, ELECTRODE INCLUDING THE COMPOSITION, AND FUEL CELL INCLUDING THE ELECTRODE | SAMSUNG ELECTRONICS CO LTD (KR) | 2016-09-15 | — | — | US | disclosed |
| US-20160228458-A1 | PREVENTING OR MITIGATING CHEMOTHERAPY INDUCED ALOPECIA USING VITAMIN D | BERG LLC | 2016-08-11 | — | — | US | disclosed |
| EP-2594556-B1 | Substituted aminopropionic derivatives as neprilysin inhibitors | NOVARTIS AG (CH) | 2016-08-10 | — | — | EP | disclosed |
| EP-2594557-B1 | Substituted aminopropionic derivatives as neprilysin inhibitors | NOVARTIS AG (CH) | 2016-08-10 | — | — | EP | disclosed |
| EP-3048100-A1 | SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS | Novartis AG (CH) | 2016-07-27 | — | — | EP | disclosed |
| EP-2735561-B1 | Substituted carbamoylmethoxyacetic acid derivatives as novel NEP inhibitors | NOVARTIS AG (CH) | 2016-07-20 | — | — | EP | disclosed |
| US-9368803-B2 | Composition, method of preparing the composition, electrode including the composition, and fuel cell including the electrode | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-06-14 | — | — | US | disclosed |
| EP-2640375-B1 | METHOD OF TREATING CONTRAST-INDUCED NEPHROPATHY | NOVARTIS AG (CH) | 2016-05-18 | — | — | EP | disclosed |
| US-9331338-B2 | Polymer composition for lithium secondary battery, electrode for lithium secondary battery including the same, and lithium secondary battery including the electrode | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-05-03 | — | — | US | disclosed |
| US-9318744-B2 | Polymer electrode for lithium secondary battery including the polymer and lithium second battery employing the electrode | SAMSUNG SDI CO., LTD. (KR) | 2016-04-19 | — | — | US | disclosed |
| EP-3003497-A1 | PREVENTING OR MITIGATING CHEMOTHERAPY INDUCED ALOPECIA USING VITAMIN D | Berg LLC (US) | 2016-04-13 | — | — | EP | disclosed |
| EP-2435402-B1 | SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS | NOVARTIS AG (CH) | 2016-04-13 | — | — | EP | disclosed |
| US-9306234-B2 | Polymer, a method of preparing the same, composite prepared from the polymer, and electrode and composite membrane each including the polymer or the composite | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-04-05 | — | — | US | disclosed |
| EP-2993169-A1 | ARYL-PYRIDINE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS | Novartis AG (CH) | 2016-03-09 | — | — | EP | disclosed |
| EP-2595229-B1 | COMPOSITION, COMPOSITE PREPARED FROM THE COMPOSITION, ELECTRODE USING THE COMPOSITION OR THE COMPOSITE, COMPOSITE MEMBRANE INCLUDING THE COMPOSITE, AND FUEL CELL INCLUDING THE COMPOSITE MEMBRANE | SAMSUNG ELECTRONICS CO LTD (KR) | 2016-02-10 | — | — | EP | disclosed |
| US-9220718-B2 | Sonosensitive liposome, pharmaceutical composition including the same, and method of delivering active agent to subject using the sonosensitive liposome | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-12-29 | — | — | US | disclosed |
| US-20150352039-A1 | SONOSENSITIVE LIPOSOME, PHARMACEUTICAL COMPOSITION INCLUDING THE SAME, AND METHOD OF DELIVERING ACTIVE AGENT TO SUBJECT USING THE SONOSENSITIVE LIPOSOME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-12-10 | — | — | US | disclosed |
| US-9178237-B2 | Conductive composition and method of preparation, polymer thereof, and electrode, electrolyte membrane and fuel cell including the composition or polymer | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-11-03 | — | — | US | disclosed |
| US-20150311537-A1 | COMPOSITION, POLYMER THEREOF, ELECTRODE AND ELECTROLYTE MEMBRANE FOR FUEL CELL, AND FUEL CELL INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-10-29 | — | — | US | disclosed |
| US-20150311557-A1 | POLYMER, A METHOD OF PREPARING THE SAME, COMPOSITE PREPARED FROM THE POLYMER, AND ELECTRODE AND COMPOSITE MEMBRANE EACH INCLUDING THE POLYMER OR THE COMPOSITE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-10-29 | — | — | US | disclosed |
| EP-2501678-B1 | ARYL-PYRIDINE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS | NOVARTIS AG (CH) | 2015-09-23 | — | — | EP | disclosed |
| US-9112232-B2 | Composition, polymer thereof, electrode and electrolyte membrane for fuel cell, and fuel cell including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-08-18 | — | — | US | disclosed |
| US-9112203-B2 | Polymer, a method of preparing the same, composite prepared from the polymer, and electrode and composite membrane each including the polymer or the composite | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-08-18 | — | — | US | disclosed |
| US-20150174089-A1 | SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS | NOVARTIS AG (CH) | 2015-06-25 | — | — | US | disclosed |
| US-9051433-B2 | Polymer and cross-linked polymer composition, electrode and electrolyte membrane including cross-linked polymer, and fuel cell including electrode and electrolyte membrane | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-06-09 | — | — | US | disclosed |
| US-20150150971-A1 | SONOSENSITIVE LIPOSOME, PHARMACEUTICAL COMPOSITION INCLUDING THE SAME, AND METHOD OF DELIVERING ACTIVE AGENT TO SUBJECT USING THE SONOSENSITIVE LIPOSOME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-06-04 | — | — | US | disclosed |
| US-9006249-B2 | Substituted aminobutyric derivatives as neprilysin inhibitors | NOVARTIS AG (CH) | 2015-04-14 | — | — | US | disclosed |
| US-9006225-B2 | Stable pharmaceutical composition | ASAHI KASEI PHARMA CORPORATION (JP) | 2015-04-14 | — | — | US | disclosed |
| US-8993631-B2 | Method of treating contrast-induced nephropathy | NOVARTIS AG (CH) | 2015-03-31 | — | — | US | disclosed |
| US-20150076414-A1 | POLYMER, ELECTRODE FOR LITHIUM BATTERIES INCLUDING THE POLYMER, AND LITHIUM BATTERY INCLUDING THE ELECTRODE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-03-19 | — | — | US | disclosed |
| US-20150064578-A1 | ELECTROLYTE FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY USING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-03-05 | — | — | US | disclosed |
| US-20150037708-A1 | POLYMER, ELECTROLYTE MEMBRANE AND ELECTRODE FOR A FUEL CELL, EACH INCLUDING THE POLYMER, FUEL CELL INCLUDING AT LEAST ONE OF THE ELECTROLYTE MEMBRANE, AND THE ELECTRODE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-02-05 | — | — | US | disclosed |
| US-8936887-B2 | Composite electrolyte membrane for fuel cell, method of manufacturing the membrane, and fuel cell including the membrane | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-01-20 | — | — | US | disclosed |
| WO-2014194133-A1 | PREVENTING OR MITIGATING CHEMOTHERAPY INDUCED ALOPECIA USING VITAMIN D | BERG LLC (US) | 2014-12-04 | — | — | WO | disclosed |
| US-8901146-B2 | Aminoalkylpyrimidine derivatives as histamine H4 receptor antagonists | MEDICIS PHARMACEUTICAL CORPORATION (US) | 2014-12-02 | — | — | US | disclosed |
| US-20140339482-A1 | COMPOSITION FOR POLARIZATION FILM, POLARIZATION FILM, AND DISPLAY DEVICE | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2014-11-20 | — | — | US | disclosed |
| US-20140336194-A1 | METHOD OF TREATING CONTRAST-INDUCED NEPHROPATHY | NOVARTIS AG (CH) | 2014-11-13 | — | — | US | disclosed |
| US-8877786-B2 | Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors | NOVARTIS AG (CH) | 2014-11-04 | — | — | US | disclosed |
| US-8877815-B2 | Substituted carbamoylcycloalkyl acetic acid derivatives as NEP | NOVARTIS AG (CH) | 2014-11-04 | — | — | US | disclosed |
| US-20140296240-A1 | SUBSTITUTED AMINOPROPIONIC DERIVATIVES AS NEPRILYSIN INHIBITORS | COPPOLA GARY MARK (US) | 2014-10-02 | — | — | US | disclosed |
| US-20140275175-A1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2014-09-18 | — | — | US | disclosed |
| US-8822534-B2 | Substituted aminopropionic derivatives as neprilysin inhibitors | NOVARTIS AG (CH) | 2014-09-02 | — | — | US | disclosed |
| US-8809545-B2 | Aryl pyridine as aldosterone synthase inhibitors | NOVARTIS AG (CH) | 2014-08-19 | — | — | US | disclosed |
| US-20140225083-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE | CHEIL INDUSTRIES INC. (KR) | 2014-08-14 | — | — | US | disclosed |
| US-20140225088-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE | CHEIL INDUSTRIES INC. (KR) | 2014-08-14 | — | — | US | disclosed |
| EP-2435409-B1 | SUBSTITUTED AMINOPROPIONIC DERIVATIVES AS NEPRILYSIN INHIBITORS | NOVARTIS AG (CH) | 2014-08-13 | — | — | EP | disclosed |
| US-8802315-B2 | Composition, composite prepared from the composition, electrode using the composition or the composite, composite membrane including the composite, and fuel cell including the composite membrane | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2014-08-12 | — | — | US | disclosed |
| US-8802320-B2 | Electrolytic membrane comprising a crystalline organic and inorganic porous composite for fuel cell, electrode and fuel cell, and fuel cell including the electrolytic membrane and/or the electrode | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2014-08-12 | — | — | US | disclosed |
| US-20140203257-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE | CHEIL INDUSTRIES INC. (KR) | 2014-07-24 | — | — | US | disclosed |
| US-8778972-B2 | 5-pyridin-3-yl-1, 3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or CYP11B1 | NOVARTIS AG (CH) | 2014-07-15 | — | — | US | disclosed |
| US-20140194581-A1 | POLYMER, A METHOD OF PREPARING THE SAME, COMPOSITE PREPARED FROM THE POLYMER, AND ELECTRODE AND COMPOSITE MEMBRANE EACH INCLUDING THE POLYMER OR THE COMPOSITE | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2014-07-10 | — | — | US | disclosed |
| EP-2735561-A1 | Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors | Novartis AG (CH) | 2014-05-28 | — | — | EP | disclosed |
| US-20140134262-A1 | METHOD OF TREATING ATHEROSCLEROSIS IN HIGH TRIGLYCERIDE SUBJECTS | NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC. | 2014-05-15 | — | — | US | disclosed |
| US-20140131630-A1 | POLYMER COMPOSITION FOR LITHIUM SECONDARY BATTERY, ELECTRODE FOR LITHIUM SECONDARY BATTERY INCLUDING THE SAME, AND LITHIUM SECONDARY BATTERY INCLUDING THE ELECTRODE | SAMSUNG SDI CO., LTD. (KR) | 2014-05-15 | — | — | US | disclosed |
| US-20140134502-A1 | ELECTROLYTE FOR SECONDARY LITHIUM BATTERY AND SECONDARY LITHIUM BATTERY USING THE SAME | SAMSUNG FINE CHEMICALS CO., LTD. (KR) | 2014-05-15 | — | — | US | disclosed |
| EP-2729142-A2 | METHOD OF TREATING ATHEROSCLEROSIS IN HIGH TRIGLYCERIDE SUBJECTS | Novartis AG (CH) | 2014-05-14 | — | — | EP | disclosed |
| EP-2365567-B1 | Composition, method of preparing the composition, electrode including the composition, and fuel cell including the electrode | SAMSUNG ELECTRONICS CO LTD (KR) | 2014-05-07 | — | — | EP | disclosed |
| EP-2501683-B1 | SUBSTITUTED CARBAMOYLMETHYLAMINO ACETIC ACID DERIVATIVES AS NOVEL NEP INHIBITORS | NOVARTIS AG (CH) | 2014-04-23 | — | — | EP | disclosed |
| EP-2719712-A1 | Polymer, electrode for lithium secondary battery including the polymer, and lithium second battery employing the electrode | Samsung SDI Co., Ltd. (KR) | 2014-04-16 | — | — | EP | disclosed |
| US-20140088165-A1 | Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors | NOVARTIS AG (CH) | 2014-03-27 | — | — | US | disclosed |
| EP-2507234-B1 | IMIDAZOLE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS | NOVARTIS AG (CH) | 2014-03-12 | — | — | EP | disclosed |
| US-8642635-B2 | Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors | NOVARTIS AG (CH) | 2014-02-04 | — | — | US | disclosed |
| EP-2429995-B1 | ARYL PYRIDINE AS ALDOSTERONE SYNTHASE INHIBITORS | NOVARTIS AG (CH) | 2014-01-22 | — | — | EP | disclosed |
| US-20130303677-A1 | COMPOSITION FOR POLARIZING FILM, POLARIZING FILM, AND DISPLAY DEVICE INCLUDING THE POLARIZING FILM | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-11-14 | — | — | US | disclosed |
| US-20130296309-A1 | ARYL PYRIDINE AS ALDOSTERONE SYNTHASE INHIBITORS | CHAMOIN SYLVIE (FR) | 2013-11-07 | — | — | US | disclosed |
| US-8575160-B2 | Imidazole derivatives as aldosterone synthase inhibitors | NOVARTIS AG (CH) | 2013-11-05 | — | — | US | disclosed |
| EP-2466675-B1 | Conductive composition and method of preparation, polymer thereof, and electrode, electrolyte membrane and fuel cell including the composition or polymer | SAMSUNG ELECTRONICS CO LTD (KR) | 2013-10-02 | — | — | EP | disclosed |
| EP-2640375-A1 | METHOD OF TREATING CONTRAST-INDUCED NEPHROPATHY | Novartis AG (CH) | 2013-09-25 | — | — | EP | disclosed |
| EP-2640689-A1 | SUBSTITUTED CARBAMOYLCYCLOALKYL ACETIC ACID DERIVATIVES AS NEP INHIBITORS | Novartis AG (CH) | 2013-09-25 | — | — | EP | disclosed |
| US-8519142-B2 | Aryl pyridine as aldosterone synthase inhibitors | NOVARTIS AG (CH) | 2013-08-27 | — | — | US | disclosed |
| US-8519134-B2 | Aryl-pyridine derivatives as aldosterone synthase inhibitors | NOVARTIS AG (CH) | 2013-08-27 | — | — | US | disclosed |
| US-20130196248-A1 | COMPOUND, COMPOSITION INCLUDING COMPOUND, COMPOSITE FORMED THEREFROM, ELECTRODE USING COMPOSITION OR COMPOSITE, COMPOSITE MEMBRANE USING COMPOSITE, AND FUEL CELL INCLUDING AT LEAST ONE SELECTED FROM ELECTRODE AND COMPOSITE MEMBRANE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-08-01 | — | — | US | disclosed |
| EP-2430018-B1 | BENZOXAZOLONE DERIVATIVES AS ALDOSTERONE SYMTHASE INHIBITORS | NOVARTIS AG (CH) | 2013-07-03 | — | — | EP | disclosed |
| US-20130157168-A1 | COMPOSITION, COMPOSITE PREPARED FROM THE COMPOSITION, ELECTRODE AND ELECTROLYTE MEMBRANE FOR FUEL CELL EACH INCLUDING THE SAME, METHOD OF PREPARING THE ELECTROLYTE MEMBRANE, AND FUEL CELL INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-06-20 | — | — | US | disclosed |
| US-8455522-B2 | Benzoxazolone derivatives as aldosterone synthase inhibitors | NOVARTIS AG (CH) | 2013-06-04 | — | — | US | disclosed |
| EP-2594557-A1 | Substituted aminopropionic derivatives as neprilysin inhibitors | Novartis AG (CH) | 2013-05-22 | — | — | EP | disclosed |
| EP-2595229-A2 | Composition, composite prepared from the composition, electrode using the composition or the composite, composite membrane including the composite, and fuel cell including the composite membrane | Samsung Electronics Co., Ltd (KR) | 2013-05-22 | — | — | EP | disclosed |
| EP-2594556-A1 | Substituted aminopropionic derivatives as neprilysin inhibitors | Novartis AG (CH) | 2013-05-22 | — | — | EP | disclosed |
| US-20130122395-A1 | COMPOSITION, COMPOSITE PREPARED FROM THE COMPOSITION, ELECTRODE USING THE COMPOSITION OR THE COMPOSITE, COMPOSITE MEMBRANE INCLUDING THE COMPOSITE, AND FUEL CELL INCLUDING THE COMPOSITE MEMBRANE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-05-16 | — | — | US | disclosed |
| US-20130096127-A1 | SUBSTITUTED AMINOPROPIONIC DERIVATIVES AS NEPRILYSIN INHIBITORS | NOVARTIS AG (CH) | 2013-04-18 | — | — | US | disclosed |
| US-20130096168-A1 | Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors | NOVARTIS AG (CH) | 2013-04-18 | — | — | US | disclosed |
| US-20130065893-A1 | IMIDAZOLE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS | NOVARTIS AG (CH) | 2013-03-14 | — | — | US | disclosed |
| US-8394853-B2 | Substituted aminopropionic derivatives as neprilysin inhibitors | NOVARTIS AG (CH) | 2013-03-12 | — | — | US | disclosed |
| US-8383827-B2 | Aryl pyridine as aldosterone synthase inhibitors | NOVARTIS AG (CH) | 2013-02-26 | — | — | US | disclosed |
| US-20130045436-A1 | POROUS MEMBRANE, ELECTROLYTE MEMBRANE INCLUDING SAME, METHODS OF MANUFACTURING BOTH, AND FUEL CELL INCLUDING AT LEAST ONE OF THE MEMBRANES | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-02-21 | — | — | US | disclosed |
| EP-2560227-A1 | Porous membrane, electrolyte membrane including same, methods of manufacturing both, and fuel cell including at least one of the membranes | Samsung Electronics Co., Ltd. (KR) | 2013-02-20 | — | — | EP | disclosed |
| US-8377978-B2 | Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors | NOVARTIS AG (CH) | 2013-02-19 | — | — | US | disclosed |
| US-20130035354-A1 | ARYL PYRIDINE AS ALDOSTERONE SYNTHASE INHIBITORS | NOVARTIS AG (CH) | 2013-02-07 | — | — | US | disclosed |
| US-20130022893-A1 | COMPOSITION, COMPOSITE MEMBRANE PREPARED FROM COMPOSITION, FUEL CELL INCLUDING THE COMPOSITE MEMBRANE, AND METHOD OF MANUFACTURING THE COMPOSITE MEMBRANE | SAMSUNG ELECTRONICS CO. LTD. (KR) | 2013-01-24 | — | — | US | disclosed |
| US-20130018031-A1 | AMINOALKYLPYRIMIDINE DERIVATIVES AS HISTAMINE H4 RECEPTOR ANTAGONISTS | MEDICIS PHARMACEUTICAL CORPORATION (US) | 2013-01-17 | — | — | US | disclosed |
| WO-2013008164-A2 | METHOD OF TREATING ATHEROSCLEROSIS IN HIGH TRIGLYCERIDE SUBJECTS | NOVARTIS AG (CH) | 2013-01-17 | — | — | WO | disclosed |
| US-20120321992-A1 | COMPOSITE ELECTROLYTE MEMBRANE FOR FUEL CELL, METHOD OF MANUFACTURING THE MEMBRANE, AND FUEL CELL INCLUDING THE MEMBRANE | SAMSUNG ELECTRONICS CO. LTD. (KR) | 2012-12-20 | — | — | US | disclosed |
| US-20120316195-A1 | ARYL-PYRIDINE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS | NOVARTIS AG (CH) | 2012-12-13 | — | — | US | disclosed |
| EP-2526945-A1 | New CRTH2 Antagonists | Almirall, S.A. (ES) | 2012-11-28 | — | — | EP | disclosed |
| EP-2507234-A1 | IMIDAZOLE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS | Novartis AG (CH) | 2012-10-10 | — | — | EP | disclosed |
| US-20120252830-A1 | Substituted Aminobutyric Derivatives as Neprilysin Inhibitors | NOVARTIS AG (CH) | 2012-10-04 | — | — | US | disclosed |
| US-20120244453-A1 | ELECTROLYTIC MEMBRANE FOR FUEL CELL, ELECTRODE FOR FUEL CELL, AND FUEL CELL INCLUDING THE ELECTROLYTIC MEMBRANE AND/OR THE ELECTRODE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2012-09-27 | — | — | US | disclosed |
| EP-2501678-A1 | ARYL-PYRIDINE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS | Novartis AG (CH) | 2012-09-26 | — | — | EP | disclosed |
| EP-2501683-A1 | SUBSTITUTED CARBAMOYLMETHYLAMINO ACETIC ACID DERIVATIVES AS NOVEL NEP INHIBITORS | Novartis AG (CH) | 2012-09-26 | — | — | EP | disclosed |
| US-8263629-B2 | Substituted aminobutyric derivatives as neprilysin inhibitors | NOVARTIS AG (CH) | 2012-09-11 | — | — | US | disclosed |
| US-20120202862-A1 | Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors | NOVARTIS AG (CH) | 2012-08-09 | — | — | US | disclosed |
| US-8222286-B2 | Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors | NOVARTIS AG (CH) | 2012-07-17 | — | — | US | disclosed |
| US-20120178013-A1 | CATALYST COATED MEMBRANE FOR FUEL CELL, MEMBRANE AND ELECTRODE ASSEMBLY (MEA) INCLUDING SAME, METHOD OF MANUFACTURING THE MEA, AND FUEL CELL INCLUDING THE MEA | SAMSUNG ELECTRONICS CO. LTD. (KR) | 2012-07-12 | — | — | US | disclosed |
| EP-2464357-A2 | VITAMIN D3 AND ANALOGS THEREOF FOR TREATING ALOPECIA | Berg Biosystems, LLC (US) | 2012-06-20 | — | — | EP | disclosed |
| EP-2466675-A1 | Conductive composition and method of preparation, polymer thereof, and electrode, electrolyte membrane and fuel cell including the composition or polymer | Samsung Electronics Co., Ltd. (KR) | 2012-06-20 | — | — | EP | disclosed |
| US-20120148938-A1 | CONDUCTIVE COMPOSITION AND METHOD OF PREPARATION, POLYMER THEREOF, AND ELECTRODE, ELECTROLYTE MEMBRANE AND FUEL CELL INCLUDING THE COMPOSITION OR POLYMER | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2012-06-14 | — | — | US | disclosed |
| EP-2457900-A1 | New pyrazole derivatives having CRTh2 antagonistic behaviour | Almirall, S.A. (ES) | 2012-05-30 | — | — | EP | disclosed |
| WO-2012065953-A1 | SUBSTITUTED CARBAMOYLCYCLOALKYL ACETIC ACID DERIVATIVES AS NEP INHIBITORS | NOVARTIS AG (CH) | 2012-05-24 | — | — | WO | disclosed |
| WO-2012065958-A1 | METHOD OF TREATING CONTRAST-INDUCED NEPHROPATHY | NOVARTIS AG (CH) | 2012-05-24 | — | — | WO | disclosed |
| US-20120122844-A1 | METHOD OF TREATING CONTRAST-INDUCED NEPHROPATHY | NOVARTIS AG (CH) | 2012-05-17 | — | — | US | disclosed |
| US-20120122764-A1 | SUBSTITUTED CARBAMOYLCYCLOALKYL ACETIC ACID DERIVATIVES AS NEP | NOVARTIS AG (CH) | 2012-05-17 | — | — | US | disclosed |
| US-20120071514-A1 | BENZOXAZOLONE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS | NOVARTIS AG (CH) | 2012-03-22 | — | — | US | disclosed |
| US-20120071512-A1 | 5-PYRIDIN-3-YL-1, 3-DIHYDRO-INDOL-2-ON DERIVATIVES AND THEIR USE AS MODULATORS OF ALDOSTERONE SYNTHASE AND/OR CYP11B1 | NOVARTIS AG (CH) | 2012-03-22 | — | — | US | disclosed |
| EP-2393494-A1 | VITAMIN D3 AND ANALOGS THEREOF FOR ALLEVIATING SIDE EFFECTS ASSOCIATED WITH CHEMOTHERAPY | Berg Biosystems, LLC (US) | 2011-12-14 | — | — | EP | disclosed |
| EP-2380890-A1 | New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors | Almirall, S.A. (ES) | 2011-10-26 | — | — | EP | disclosed |
| US-20110253549-A1 | WASHING APPARATUS AND METHOD OF DEODORIZING WASHING WATER | KANNO MINORU | 2011-10-20 | — | — | US | disclosed |
| EP-2365567-A2 | Composition, method of preparing the composition, electrode including the composition, and fuel cell including the electrode | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2011-09-14 | — | — | EP | disclosed |
| WO-2011108861-A2 | COMPOSITION, METHOD OF PREPARING THE COMPOSITION, ELECTRODE INCLUDING THE COMPOSITION, AND FUEL CELL INCLUDING THE ELECTRODE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2011-09-09 | — | — | WO | disclosed |
| US-20110217627-A1 | COMPOSITION, METHOD OF PREPARING THE COMPOSITION, ELECTRODE INCLUDING THE COMPOSITION, AND FUEL CELL INCLUDING THE ELECTRODE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2011-09-08 | — | — | US | disclosed |
| US-20110195340-A1 | COMPOSITION, POLYMER THEREOF, ELECTRODE AND ELECTROLYTE MEMBRANE FOR FUEL CELL, AND FUEL CELL INCLUDING THE SAME | SAMSUNG ELECTRONICS CO. LTD (KR) | 2011-08-11 | — | — | US | disclosed |
| US-20110189584-A1 | POLYMER AND CROSS-LINKED POLYMER COMPOSITION, ELECTRODE AND ELECTROLYTE MEMBRANE INCLUDING CROSS-LINKED POLYMER, AND FUEL CELL INCLUDING ELECTRODE AND ELECTROLYTE MEMBRANE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2011-08-04 | — | — | US | disclosed |
| US-20110189581-A1 | COMPOUND, CROSS-LINKED MATERIAL THEREOF, DOUBLE CROSS-LINKED POLYMER THEREOF, AND ELECTROLYTE MEMBRANE, ELECTRODE FOR FUEL CELL AND FUEL CELL INCLUDING SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2011-08-04 | — | — | US | disclosed |
| WO-2011064376-A1 | IMIDAZOLE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS | NOVARTIS AG (CH) | 2011-06-03 | — | — | WO | disclosed |
| US-20110124695-A1 | Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors | NOVARTIS AG (CH) | 2011-05-26 | — | — | US | disclosed |
| WO-2011061271-A1 | SUBSTITUTED CARBAMOYLMETHYLAMINO ACETIC ACID DERIVATIVES AS NOVEL NEP INHIBITORS | NOVARTIS AG (CH) | 2011-05-26 | — | — | WO | disclosed |
| WO-2011061168-A1 | ARYL-PYRIDINE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS | NOVARTIS AG (CH) | 2011-05-26 | — | — | WO | disclosed |
| US-20110059917-A1 | VITAMIN D3 AND ANALOGS THEREOF FOR TREATING ALOPECIA | BERG, KARA ANN | 2011-03-10 | — | — | US | disclosed |
| WO-2011019617-A2 | VITAMIN D3 AND ANALOGS THEREOF FOR TREATING ALOPECIA | CYTOTECH LABS, LLC (US) | 2011-02-17 | — | — | WO | disclosed |
| US-20100305145-A1 | Substituted Aminobutyric Derivatives as Neprilysin Inhibitors | NOVARTIS AG (CH) | 2010-12-02 | — | — | US | disclosed |
| US-20100305131-A1 | Substituted Aminopropionic Derivatives as Neprilysin inhibitors | NOVARTIS AG (CH) | 2010-12-02 | — | — | US | disclosed |
| US-20100292225-A1 | ARYL PYRIDINE AS ALDOSTERONE SYNTHASE INHIBITORS | NOVARTIS AG (CH) | 2010-11-18 | — | — | US | disclosed |
| EP-2236135-A1 | STABLE PHARMACEUTICAL COMPOSITION | Asahi Kasei Pharma Corporation (JP) | 2010-10-06 | — | — | EP | disclosed |
| WO-2010088304-A1 | VITAMIN D3 AND ANALOGS THEREOF FOR ALLEVIATING SIDE EFFECTS ASSOCIATED WITH CHEMOTHERAPY | CYTOTECH LABS, LLC (US) | 2010-08-05 | — | — | WO | disclosed |
| US-20100196308-A1 | VITAMIN D3 AND ANALOGS THEREOF FOR ALLEVIATING SIDE EFFECTS ASSOCIATED WITH CHEMOTHERAPY | BERG LLC | 2010-08-05 | — | — | US | disclosed |
| US-20100048893-A1 | Substituted arylalkanoic acid derivatives and use thereof | ASAHI KASEI PHARMA CORPORATION (JP) | 2010-02-25 | — | — | US | disclosed |
| US-20100041725-A1 | STABLE PHARMACEUTICAL COMPOSITION | ASAHI KASEI PHARMA CORPORATION (JP) | 2010-02-18 | — | — | US | disclosed |
| EP-2006271-A9 | SUBSTITUTED BICYCLIC CYCLIC DERIVATIVE AND USE THEREOF | Asahi Kasei Pharma Corporation (JP) | 2009-07-29 | — | — | EP | disclosed |
| US-20090062530-A1 | Substituted arylalkanoic acid derivatives and use thereof | ASAHI KASEI PHARMA CORPORATION (JP) | 2009-03-05 | — | — | US | disclosed |
| US-20090054401-A1 | Substituted bicyclic derivatives and use thereof | ASAHI KASEI PHARMA CORPORATION (JP) | 2009-02-26 | — | — | US | disclosed |
| US-7470807-B2 | Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate | ASAHI KASEI PHARMA CORPORATION (JP) | 2008-12-30 | — | — | US | disclosed |
| EP-2006271-A2 | SUBSTITUTED BICYCLIC CYCLIC DERIVATIVE AND USE THEREOF | Asahi Kasei Pharma Corporation (JP) | 2008-12-24 | — | — | EP | disclosed |
| US-20070213333-A1 | Substituted arylalkanoic acid derivatives and use thereof | ASAHI KASEI PHAMA CORPORATION (JP) | 2007-09-13 | — | — | US | disclosed |
| EP-1660427-A4 | SUBSTITUTED ARYLALKANOIC ACID DERIVATIVE AND USE THEREOF | ASAHI KASEI PHARMA CORP (JP) | 2006-12-20 | — | — | EP | disclosed |
| EP-1660427-A1 | SUBSTITUTED ARYLALKANOIC ACID DERIVATIVE AND USE THEREOF | Asahi Kasei Pharma Corporation (JP) | 2006-05-31 | — | — | EP | disclosed |
| WO-2005016862-A1 | SUBSTITUTED ARYLALKANOIC ACID DERIVATIVE AND USE THEREOF | ASAHI KASEI PHARMA CORPORATION (JP) | 2005-02-24 | — | — | WO | disclosed |
| WO-2005016862-A1 | SUBSTITUTED ARYLALKANOIC ACID DERIVATIVE AND USE THEREOF | ASAHI KASEI PHARMA CORPORATION (JP) | 2005-02-24 | — | — | WO | disclosed |